Search

Author/Creator Sachdev, Jasgit

2. IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin–paclitaxel, with or without bevacizumab in patients with advanced cancer. Issue 3 (24th March 2022)

Authors:
Yap, Timothy A; Bessudo, Alberto; Hamilton, Erika; Sachdev, Jasgit; Patel, Manish R; Rodon, Jordi; Evilevitch, Lena; Duncan, Meghan; Guo, Wei; Kumar, Sujatha; Lu, Sharon; Dezube, Bruce J; Gabrail, Nashat
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and pharmacokinetics of veliparib extended‐release in patients with advanced solid tumors: a phase I study. (7th May 2018)

Authors:
Werner, Theresa L.; Sachdev, Jasgit; Swisher, Elizabeth M.; Gutierrez, Martin; Kittaneh, Muaiad; Stein, Mark N.; Xiong, Hao; Dunbar, Martin; Sullivan, Danielle; Komarnitsky, Philip; McKee, Mark; Tan, Antoinette R.
Journal:
Cancer medicine
Issue:
Volume 7:Number 6(2018:Jun.)
Page Start:
2360
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗